The Mother Hormone

Pregnenolone is the upstream precursor to nearly every steroid hormone in the body — and a neurosteroid that directly supports brain function, mood, and memory.

Pregnenolone is the starting point for nearly all your steroid hormones — your body makes it from cholesterol and then converts it into progesterone, DHEA, cortisol, estrogen, and testosterone, among others. Levels peak in your twenties and steadily decline with age. But pregnenolone isn't just a passive raw material: it acts as a neurosteroid, directly influencing memory, mood, and brain function. Low levels have been linked to cognitive decline, mood disorders, and poor stress resilience [1][2].

How Pregnenolone Works

Pregnenolone is synthesized in the mitochondria of cells in the adrenal glands, brain, and gonads, where an enzyme called CYP11A1 cleaves the side chain off cholesterol. From there, it enters the steroidogenesis cascade — the branching pathway that produces all your sex and stress hormones.

What makes pregnenolone unusual is that it doesn't just serve as a hormonal raw material. It is a neurosteroid: it is produced within the brain itself and acts directly on neurons and synapses. Pregnenolone sulfate (the sulfated form that predominates in the central nervous system) modulates GABA-A receptors (reducing inhibitory signaling) and NMDA receptors (enhancing excitatory signaling), which together sharpen alertness, attention, and memory encoding [1].

The Hormone Cascade

A single molecule of pregnenolone can become many different things depending on which enzymes are active:

Progesterone — regulates the menstrual cycle, supports pregnancy, calms the nervous system
DHEA — the upstream precursor to estrogen and testosterone
Cortisol — the primary stress hormone
Aldosterone — regulates sodium and blood pressure

This means pregnenolone supplementation can shift downstream hormone levels in ways that are difficult to predict without testing. It tends to convert preferentially toward whatever pathways the body needs most, though this is influenced by individual genetics and enzyme activity.

Age-Related Decline

Pregnenolone production drops significantly with age — mirroring the well-documented decline of DHEA (see our DHEA page). By age 75, pregnenolone levels are roughly 60% lower than in young adulthood. This decline coincides with the well-known pattern of hormonal aging: reduced resilience to stress, worsening sleep quality, declining libido, and reduced cognitive sharpness.

Dosage

Research studies have used doses ranging from 50 mg to 500 mg daily. For general supplementation, most practitioners use 10–50 mg per day, ideally taken in the morning (as it can be stimulating). Because it affects downstream hormones, periodic blood testing — including a full hormone panel — is advisable when supplementing long-term.

Cross-reference: See our DHEA page for how the closely related DHEA fits into this same cascade, and the adrenal health page for the broader HPA axis context.

Evidence Review

Cognitive Function

The strongest mechanistic basis for pregnenolone's cognitive effects comes from studies of its sulfated form. A review of animal and human data found that pregnenolone sulfate enhances acetylcholine release in key memory centers including the hippocampus and prefrontal cortex, and blocks the memory-impairing effects of scopolamine (a muscarinic receptor blocker) [1]. In animal models, direct administration of pregnenolone sulfate improves spatial learning and retention in dose-dependent fashion.

In humans, a proof-of-concept randomized controlled trial (n=21, 8 weeks, pregnenolone up to 500 mg/day) in patients with schizophrenia showed improvements in verbal memory, working memory, and attention, with z-score improvements 0.61 greater than placebo on a composite cognitive battery [2]. Effect sizes were modest but meaningful for a proof-of-concept design, and tolerability was good. These findings suggest pregnenolone may have a role in supporting cognitive performance when levels are depleted, though data in healthy adults remain limited.

Mood and Depression

A randomized, double-blind, placebo-controlled trial (n=80, 12 weeks) tested pregnenolone (titrated to 500 mg/day) as adjunct therapy for bipolar depression [3]. Remission rates were significantly higher in the pregnenolone group (61%) compared to placebo (37%), and the supplement was well tolerated. Depression symptom scores (MADRS) showed greater improvement in the active arm, with women showing a more robust response than men. Mechanistically, the authors attributed part of the effect to conversion of pregnenolone into allopregnanolone — a potent GABA-A modulator that has antidepressant properties.

The stress-reducing effects also appear relevant to substance use: a trial in individuals with cocaine use disorder found that pregnenolone significantly reduced cue-induced cocaine craving and self-reported anxiety compared to placebo.

Anti-Inflammatory Activity

Preclinical research has shown that pregnenolone can suppress innate immune signaling by promoting degradation of TRAF6, a key adaptor protein in the Toll-like receptor pathway [4]. This anti-inflammatory mechanism is distinct from its hormonal actions and may contribute to neuroprotection. Whether this translates clinically at supplemental doses is not yet established.

Evidence Strength and Limitations

The evidence base for pregnenolone supplementation is promising but early. Most trials are small, short-duration proof-of-concept studies in clinical populations (schizophrenia, bipolar disorder) rather than healthy adults. The cognitive and mood effects are plausible given well-understood mechanisms, but confirming benefit in general populations requires larger trials. The unpredictable downstream hormone conversion also means individual responses can vary considerably — some people may produce more estrogen or cortisol, others more DHEA or progesterone. Supplementation in hormone-sensitive conditions (breast cancer, endometriosis, prostate cancer, uterine fibroids) is contraindicated.

References

Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive agingVallee M, Mayo W, Le Moal M. Brain Research Reviews, 2001. PubMed 11744095 →
Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophreniaMarx CE, Keefe RS, Buchanan RW, et al.. Neuropsychopharmacology, 2009. PubMed 19339966 →
A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depressionBrown ES, Park J, Marx CE, et al.. Neuropsychopharmacology, 2014. PubMed 24917198 →
The neurosteroid pregnenolone promotes degradation of key proteins in the innate immune signaling to suppress inflammationLanglands SJ, Bhatt DL, et al.. eLife, 2019. Source →